UCB - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

UCB’s trial of bimekizumab in psoriasis patients meets goals

UCB
UCB’s bimekizumab yields positive results in Phase III BE VIVID trial. Credit: UCB S.A.